Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

Rhea-AI Summary

Kiniksa Pharmaceuticals (Nasdaq: KNSA) will host a conference call and live webcast on Tuesday, July 28, 2026 at 8:30 a.m. Eastern Time to report its second quarter 2026 financial results and recent portfolio execution. The live webcast and replay will be available via the Investors & Media section of Kiniksa’s website.

News Market Reaction – KNSA

-0.33%

-0.33% Session close to close

In the Jul 24 session, KNSA declined 0.33%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Net Selling was recorded in KNSA’s recent insider context, adding an ownership consideration to this...

Analysis

Net Selling was recorded in KNSA’s recent insider context, adding an ownership consideration to this earnings-date notice. Tag-specific history was mixed, with reactions of -0.6% and 1.27%; the subsequent reported results remain the key information.

Key Figures

Reporting period: Second quarter 2026 Report date: July 28, 2026 Call time: 8:30 a.m. Eastern Time +1 more

4 metrics

Reporting period Second quarter 2026 Financial results to be reported

Report date July 28, 2026 Scheduled conference call and webcast

Call time 8:30 a.m. Eastern Time Scheduled conference call and live webcast

Replay availability Approximately 48 hours After the event

Previous Earnings date Reports

2 past events · Latest: Apr 23 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 23	Earnings-date notice	Neutral	-0.6%	Announced first-quarter results date, conference call, webcast, and replay availability.
Feb 19	Earnings-date notice	Neutral	+1.3%	Announced fourth-quarter and full-year results date, call time, webcast, and replay details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Tag-specific earnings-date announcements produced mixed reactions, ranging from -0.6% to 1.27%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON, July 23, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 28, 2026 at 8:30 a.m. Eastern Time to report its second quarter 2026 financial results and recent portfolio execution.

A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts!^®

Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com

FAQ

When will Kiniksa Pharmaceuticals (KNSA) report its Q2 2026 financial results?

Kiniksa Pharmaceuticals will report its Q2 2026 financial results on July 28, 2026, at 8:30 a.m. Eastern Time via conference call and webcast. According to Kiniksa, the event will also cover recent portfolio execution updates for investors.

How can investors access the Kiniksa (KNSA) Q2 2026 earnings conference call?

Investors can access the Kiniksa Q2 2026 earnings call via a live webcast in the Investors & Media section of www.kiniksa.com. According to Kiniksa, telephone participants must register online to receive dial-in details, a unique passcode, and registrant ID.

Will there be a replay of the Kiniksa (KNSA) Q2 2026 earnings webcast?

Yes, a replay of the Kiniksa Q2 2026 earnings event will be available on the company’s website. According to Kiniksa, the replay should be accessible within approximately 48 hours after the conference call and webcast conclude for later investor review.

Where will Kiniksa (KNSA) host the live webcast for its July 28, 2026 earnings call?

The live webcast for Kiniksa’s July 28, 2026 earnings call will be hosted on the Investors & Media section of www.kiniksa.com. According to Kiniksa, this webcast will cover Q2 2026 financial results and recent portfolio execution developments.

Do investors need to register to join the Kiniksa (KNSA) Q2 2026 earnings call by phone?

Yes, investors must register online to join the Kiniksa Q2 2026 earnings call by telephone. According to Kiniksa, registrants receive a confirmation email with dial-in number, unique passcode, and registrant ID needed to access the live conference call.

What topics will Kiniksa Pharmaceuticals (KNSA) discuss on the July 28, 2026 call?

Kiniksa plans to discuss its second quarter 2026 financial results and recent portfolio execution on the July 28, 2026 call. According to Kiniksa, these updates will inform investors about financial performance and progress across its therapeutic portfolio.